Potential Failure of Novel-generation Oral Anticoagulants in Preventing Pulmonary Embolism: A Case Report and Current Literature Review

This publication has 8 references indexed in Scilit:

• Non-vitamin K Antagonist Oral Anticoagulants (NOACs) Versus Warfarin in Patients with Atrial Fibrillation Using P-gp and/or CYP450-Interacting Drugs: a Systematic Review and Meta-analysis
  Cardiovascular Drugs and Therapy, 2021
• Quality of life in patients with pulmonary embolism treated with edoxaban versus warfarin
  Research and Practice in Thrombosis and Haemostasis, 2021
• Response to the Editor: Warfarin versus non‐vitamin K oral anticoagulants for left atrial appendage thrombus: A meta‐analysis
  Journal of Cardiovascular Electrophysiology, 2020
• 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)
  European Heart Journal, 2019
• Possible failure of novel direct-acting oral anticoagulants in management of pulmonary embolism: a case report
  Journal of Medical Case Reports, 2016
• Epidemiology of venous thromboembolism
  Nature Reviews Cardiology, 2015
• Oral Apixaban for the Treatment of Acute Venous Thromboembolism
  New England Journal of Medicine, 2013
• Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
  New England Journal of Medicine, 2012